ALS gene hunt: vitamin d clues under microscope

NCT ID NCT02893605

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at genetic differences in vitamin D processing and action in 400 people with ALS and 400 healthy controls. Researchers analyzed DNA samples to find variations in eight specific genes. The goal was to better understand the biology of ALS, not to test a new drug or treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help researchers understand how vitamin D-related genes might influence ALS, potentially pointing toward new avenues for future treatments.

What could go wrong

This is an observational study, not a treatment trial. It only looks at genetic differences and does not test any therapy, so it cannot directly lead to a cure or symptom relief.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

amyotrophic lateral sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Montpellier - Hôpital Gui de Chauliac

    Montpellier, 34295, France